Abstract
Thirteen adults with temper outbursts and residual attention deficit disorder (ADD) were given propranolol to 640 mg/day in an open study. Eleven of the patients improved, with improvement in temper and other symptoms of ADD, indicating a need for controlled studies. This suggests a novel pharmacological approach to residual ADD.
Publication types
-
Case Reports
-
Clinical Trial
-
Controlled Clinical Trial
MeSH terms
-
Adolescent
-
Adult
-
Attention Deficit Disorder with Hyperactivity / complications
-
Attention Deficit Disorder with Hyperactivity / drug therapy*
-
Female
-
Humans
-
Impulsive Behavior / complications
-
Impulsive Behavior / drug therapy*
-
Male
-
Propranolol / therapeutic use*